SUMI CHAMEROY: Open Payments
NPI 1235743675 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 21 payments from 10 companies in 2025. Trend: 2023 $391 · 2024 $300 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $105 |
| ABBVIE INC. | 5 | $89 |
| Lilly USA, LLC | 3 | $61 |
| Organon LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| PFIZER INC. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, VRAYLAR, MOUNJARO, NEXPLANON, NURTEC ODT, FARXIGA, Veozah, Cologuard Collection Kit.
Industry payments across VA — which companies pay providers there.
